Cite
Verboon C, Harbo T, Cornblath DR, et al. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study. J Neurol Neurosurg Psychiatry. 2021;92(10):1080-1088doi: 10.1136/jnnp-2020-325815.
Verboon, C., Harbo, T., Cornblath, D. R., Hughes, R. A. C., van Doorn, P. A., Lunn, M. P., Gorson, K. C., Barroso, F., Kuwabara, S., Galassi, G., Lehmann, H. C., Kusunoki, S., Reisin, R. C., Binda, D., Cavaletti, G., Jacobs, B. C. (2021). Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study. Journal of neurology, neurosurgery, and psychiatry, 92(10), 1080-1088. https://doi.org/10.1136/jnnp-2020-325815
Verboon, Christine, et al. "Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study." Journal of neurology, neurosurgery, and psychiatry vol. 92,10 (2021): 1080-1088. doi: https://doi.org/10.1136/jnnp-2020-325815
Verboon C, Harbo T, Cornblath DR, Hughes RAC, van Doorn PA, Lunn MP, Gorson KC, Barroso F, Kuwabara S, Galassi G, Lehmann HC, Kusunoki S, Reisin RC, Binda D, Cavaletti G, Jacobs BC. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study. J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1080-1088. doi: 10.1136/jnnp-2020-325815. Epub 2021 Jun 08. PMID: 34103340; PMCID: PMC8458059.
Copy
Download .nbib